NCT01031927View on ClinicalTrials.gov

N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 28, 2009

Conditions
Obsessive Compulsive Disorder
Interventions
DRUG

N-methyl glycine

staring from 500mg/day, increased by 500mg biweekly, up to maximin of 2000mg/day

Trial Locations (1)

Unknown

China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

Taipei City Hospital

OTHER_GOV

lead

China Medical University Hospital

OTHER

NCT01031927 - N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD) | Biotech Hunter | Biotech Hunter